Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Large Cap
Anthem Biosciences Ltd.
₹744
₹720.95
₹749.00
₹579.15
₹873.50
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 416.58 | 552.23 | 538.01 | 478.98 | 498.26 |
| Operating Expense | 253.53 | 326.57 | 342.58 | 280.87 | 331.40 |
| Operating Profit | 163.05 | 225.66 | 195.43 | 198.11 | 166.86 |
| Depreciation | 26.75 | 23.92 | 22.61 | 20.99 | 19.50 |
| Interest | 1.13 | 2.23 | 1.61 | 2.10 | 1.78 |
| Tax | 37.98 | 54.87 | 50.60 | 90.28 | 41.91 |
| Net Profit | 112.12 | 198.43 | 148.34 | 122.56 | 127.99 |
₹744.00
↗ Bullish Moving Average
14
↘ Bearish Moving Average
0
| Held By | Sep 2025 | Dec 2025 |
|---|---|---|
| Promoter | 74.7 | 74.7 |
| FII | 1.7 | 1.4 |
| DII | 7.2 | 7.6 |
| Public | 16.4 | 16.3 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 3.24 L | 7.85 L | 41.35% |
| Week | 3.97 L | 5.92 L | 67.12% |
| 1 Month | 3.31 L | 4.74 L | 69.76% |
| 6 Month | 4.3 L | 6.07 L | 70.79% |
Positive Breakout First Resistance ( LTP > R1)
Benjamin Graham Value Screen
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Companies with Low Debt
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
RSI indicating price strength
Top Gainers
Insiders bought stocks
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹1,003 | ₹1,600 | ₹2,084 | ₹1,749.80 | ₹1,098.05 |
| % Change | 2.55% | -0.31% | 1.45% | 0.04% | 1.32% |
| Revenue TTM (₹ Cr) | ₹2,169.86 | ₹8,850.08 | ₹13,914.08 | ₹6,112.77 | ₹6,721.63 |
| Net Profit TTM (₹ Cr) | ₹332.94 | ₹869.92 | ₹1,779.35 | ₹847.18 | ₹843.32 |
| PE TTM | 63.50 | 34.90 | 48.20 | 33.90 | 70.30 |
| 1 Year Return | 56.03 | 76.73 | -10.15 | 25.06 | 94.66 |
| ROCE | 12.51 | 20.80 | 13.27 | 11.43 | 11.82 |
Alkem Laboratories Ltd.
₹ 5435.50
+1.21%
Biocon Ltd.
₹ 348.00
+0.67%
Divi's Laboratories Ltd.
₹ 6120.00
+2.81%
Ajanta Pharma Ltd.
₹ 2804.90
+1.96%
Glenmark Pharmaceuticals Ltd.
₹ 2163.50
-0.26%
Wockhardt Ltd.
₹ 1345.00
-1.80%
Aurobindo Pharma Ltd.
₹ 1352.20
+0.88%
Natco Pharma Ltd.
₹ 1103.50
-1.80%
Sun Pharmaceutical Industries Ltd.
₹ 1655.00
-3.62%
Ipca Laboratories Ltd.
₹ 1455.50
+0.39%
J B Chemicals & Pharmaceuticals Ltd.
₹ 2000.90
+1.56%
AstraZeneca Pharma India Ltd.
₹ 8302.00
+3.12%
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2393.30
+1.42%
Pfizer Ltd.
₹ 4861.10
+2.36%
Abbott India Ltd.
₹ 25810.00
+0.12%
Torrent Pharmaceuticals Ltd.
₹ 4146.00
+1.26%
Lupin Ltd.
₹ 2333.80
+1.69%
Dr. Reddy's Laboratories Ltd.
₹ 1229.00
+1.41%
Cipla Ltd.
₹ 1229.80
+0.44%
By signing up I certify terms, conditions & privacy policy